With semis whipping around on every AI headline and index volatility spiking, I’m looking for a counterpoint, a stable, cash-generating business where I can sell volatility instead of buying drama.
Cigna (CI) fits the bill — and I’d rather write my way into the stock than chase it.
Cigna isn’t a growth story. Revenue growth is steady if modest compared to the eye-watering numbers coming out of the semis. The company beat in the first quarter, reporting adjusted EPS of $7.79, and raised full-year guidance to at least $30.35 per share, extending a multi-year pattern of adjusted EPS growth. That marked the 5th consecutive (albeit modest) quarterly EPS beat. The stock is also supported by a substantial buyback program; ~ $2.5 billion remains on the $6 billion repurchase program announced early last year.
Source: https://www.cnbc.com/2026/06/10/volatility-surge-has-trader-eyeing-one-stable-stock.html